Patent · US Expired

Cardiodilatin fragment, process for preparing same and use thereof

US5665861A · kind A · utility

8Cited by

6References

10Claims

0Family size

Assignee

Haemopep Pharma GmbH · DE

Inventors

Wolf-Georg Forssmann · Hannover, DE
Jeanette M. Alt · Burgwedel, DE
Gerhard Becker · Neckargemünd, DE
Franz Herbst · Leimen, DE

Key dates

Filing date	Jun 7, 1995
Grant date	Sep 9, 1997
Priority date	—
Expiry date	Jun 7, 2015

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S530/834
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described is a peptide fragment which comprises the amino acid sequence 95-126 of ANF/CDD 1-126 (gamma-hANaP) and is formed in the kidney. The fragment urodilatin (ANF/CDD 95-126) has the following amino acid sequence: ##STR1## wherein R.sup.1 and R.sup.2 each represent further peptide fragments of ANF/CDD 1-126 (gamma-hANaP). In the amino acid sequence R.sup.1 is Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser and R.sup.2 is Asn-Ser-Phe-Arg-Tyr. Further described are processes for the preparation and/or recovery of the new peptide fragment and a medicament containing urodilatin (ANF/CDD 95-126) as well as medical indications of the medicament.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.